Goldman Sachs analyst Robert Koort upgrades Huntsman (NYSE:HUN) from Neutral to Buy and announces $43 price target.
Needham Maintains Buy on Medtronic, Lowers Price Target to $145
Needham analyst Mike Matson maintains Medtronic (NYSE:MDT) with a Buy and lowers the price target from $152 to $145.